Teenage Smoking Rate Decreased, but E-cigarette Use Increased

Aug.21.2023
Teenage Smoking Rate Decreased, but E-cigarette Use Increased
Teenage smoking rates decline during COVID-19, but e-cigarette use increases, alcohol consumption remains stable, and mental health deteriorates.

According to a recent survey conducted by the Korea Centers for Disease Control and Prevention (KCDC), the overall smoking rate among teenagers has decreased in the past two years since the outbreak of COVID-19. The survey, titled the "17th Youth Health Behavior Survey," collected data from approximately 60,000 students from middle school first grade to high school third grade between August and November last year.

 

The statistics revealed that the smoking and drinking habits of teenagers remained stable in 2020, after experiencing a significant drop compared to 2019, the year before the COVID-19 pandemic. The percentage of teenagers who reported smoking cigarettes for more than one day in the past month was 4.5%, a similar level to the previous year (4.4%), and lower than the pre-pandemic rate of 6.7% in 2019.

 

The KCDC attributed this trend to the increase in remote learning and the decrease in peer gatherings during the pandemic period. However, the use of e-cigarettes increased, with the usage rates of liquid-type e-cigarettes rising from 1.9% to 2.9% in a year, and cartridge-type e-cigarettes increasing from 1.1% to 1.4%.

 

In terms of alcohol consumption, the percentage of teenagers who reported drinking at least one glass in the past 30 days remained the same at 10.7%. The "current drinking rate" also showed no significant increase since it dropped from 15.0% in 2019 to 10.7% in 2020.

 

While the average alcohol consumption rate in the past month decreased slightly from 5.2% in 2020 to 4.9% in 2021, indicating a decline in risky drinking behaviors, the accessibility to purchase tobacco and alcohol increased. The percentage of teenagers who reported that they could easily buy cigarettes or alcohol from convenience stores or shops increased significantly compared to the previous year, with the accessibility rate for cigarette purchases rising from 67.0% to 74.8% and for alcohol purchases from 63.5% to 71.3%.

 

While the percentage of teenagers engaging in regular physical activities increased slightly to 14.6% who participated in at least 60 minutes of physical activity for five or more days a week, the dietary habits did not improve. The percentage of teenagers skipping breakfast for five or more days a week continued to rise, reaching 38.0% in 2021, compared to 27.9% in 2015. Additionally, the percentage of teenagers consuming fruits decreased for the fifth consecutive year, recording 18.1% in 2021.

 

Mental health indicators also worsened in 2021 compared to the previous year. The prevalence of depression increased from 25.2% in 2020 to 26.8%, and the perceived stress rate rose from 34.2% to 38.8%. Females showed higher rates of depression (31.4%) and stress (45.6%) compared to males (22.4% and 32.3% respectively).

 

In conclusion, while the smoking rate among teenagers has decreased during the COVID-19 pandemic, the use of e-cigarettes has increased. Additionally, there has been no significant change in alcohol consumption, but the accessibility to purchase tobacco and alcohol has increased. Furthermore, despite a slight increase in regular physical activity, detrimental dietary habits and worsening mental health indicators are concerning issues among teenagers.


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang Industrial Co., Ltd. has filed a patent application for an oral nicotine delivery product designed to let users actively adjust nicotine release. The product embeds two types of nicotine reservoirs with different wall thicknesses and positions inside a deformable matrix. Pressure applied with the tongue or lips can rupture the reservoirs and accelerate nicotine release. In simulated oral tests, several patent examples showed sharply higher peak nicotine release rates as applied force increased from 0 N to 1 N and 3 N. The filing explores a shift from preset release profiles toward user-triggered nicotine delivery.
Sep.01
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland has increased tobacco excise under Budget 2027 and announced a further rise in its E-liquid Products Tax. From Oct. 7, the tax burden on a pack of 20 cigarettes in the most popular price category increased by €1, with pro-rata increases on other tobacco products. The government plans to raise EPT from €0.50 to €0.70 per millilitre from Jan. 1, 2027, a 40% increase applying to both nicotine-containing and nicotine-free e-liquids. The tobacco duty increase is expected to raise about €63.1 million in a full year.
Regulations
Oct.09